X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (356) 356
cardiac & cardiovascular systems (286) 286
female (218) 218
male (218) 218
middle aged (179) 179
aged (175) 175
treatment outcome (129) 129
risk factors (123) 123
abridged index medicus (118) 118
mortality (108) 108
cardiovascular (107) 107
heart attacks (105) 105
atrial fibrillation (103) 103
acute coronary syndromes (91) 91
internal medicine (80) 80
cardiology (79) 79
anticoagulants (73) 73
myocardial infarction - drug therapy (73) 73
heart attack (72) 72
stroke (72) 72
coronary heart disease (71) 71
warfarin (71) 71
analysis (69) 69
electrocardiography (68) 68
care and treatment (67) 67
drug therapy (66) 66
risk (65) 65
double-blind method (62) 62
clinical trials (59) 59
peripheral vascular disease (57) 57
acute myocardial-infarction (53) 53
myocardial-infarction (53) 53
anticoagulants - therapeutic use (52) 52
cardiac patients (52) 52
fibrinolytic agents - therapeutic use (52) 52
cardiovascular disease (51) 51
myocardial infarction (51) 51
cholesterol (50) 50
outcomes (50) 50
time factors (49) 49
drug therapy, combination (48) 48
thrombolytic therapy (48) 48
edoxaban (47) 47
therapy (47) 47
coronary angiography (46) 46
prognosis (46) 46
atrial fibrillation - drug therapy (45) 45
myocardial infarction - mortality (45) 45
acute coronary syndrome (44) 44
adult (44) 44
platelet aggregation inhibitors - therapeutic use (43) 43
cardiovascular diseases (40) 40
follow-up studies (40) 40
hemorrhage - chemically induced (39) 39
patient outcomes (39) 39
prevention (39) 39
research (39) 39
risk assessment (39) 39
unstable angina (39) 39
metaanalysis (38) 38
myocardial infarction - therapy (38) 38
stroke - prevention & control (38) 38
cardiology and cardiovascular medicine (37) 37
diabetes (37) 37
safety (37) 37
thrombolysis (37) 37
atrial fibrillation - complications (36) 36
medical research (36) 36
acute coronary syndrome - drug therapy (34) 34
health aspects (34) 34
medical colleges (34) 34
platelet glycoprotein gpiib-iiia complex - antagonists & inhibitors (34) 34
dose-response relationship, drug (33) 33
ezetimibe (33) 33
medicine & public health (33) 33
medicine, experimental (33) 33
aged, 80 and over (32) 32
anticoagulation (32) 32
heart failure (32) 32
management (32) 32
medicine, general & internal (32) 32
statins (32) 32
cholesterol, ldl - blood (31) 31
coronary vessels (31) 31
randomized controlled trials as topic (31) 31
angioplasty (30) 30
anticoagulants - administration & dosage (30) 30
dabigatran (30) 30
patients (30) 30
administration, oral (29) 29
cardiac arrhythmia (29) 29
efficacy (29) 29
transluminal angioplasty (29) 29
trial (29) 29
usage (29) 29
acute coronary syndrome - therapy (28) 28
aspirin (28) 28
clopidogrel (28) 28
dosage and administration (28) 28
lipids (28) 28
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the American College of Cardiology, ISSN 0735-1097, 2013, Volume 61, Issue 25, pp. 2495 - 2502
Journal Article
The American heart journal, ISSN 0002-8703, 2008, Volume 156, Issue 5, pp. 826 - 832
Journal Article
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2017, Volume 376, Issue 18, pp. 1713 - 1722
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2009, Volume 360, Issue 21, pp. 2176 - 2190
Journal Article
American Heart Journal, ISSN 0002-8703, 2015, Volume 171, Issue 1, pp. 25 - 32
Journal Article
American Heart Journal, ISSN 0002-8703, 2014, Volume 168, Issue 2, pp. 205 - 212.e1
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2012, Volume 380, Issue 9858, pp. 2007 - 2017
Journal Article
The American heart journal, ISSN 0002-8703, 2016, Volume 173, pp. 94 - 101
Background Despite current therapies, patients with vascular disease remain at high risk for major adverse cardiovascular events. Low-density lipoprotein... 
Cardiovascular | FAMILIAL HYPERCHOLESTEROLEMIA | CARDIAC & CARDIOVASCULAR SYSTEMS | MYOCARDIAL-INFARCTION | EVOLOCUMAB AMG 145 | STATIN THERAPY | LDL-C | LOW-DENSITY-LIPOPROTEIN | PRIMARY-PREVENTION TRIAL | MONOCLONAL-ANTIBODY | PLACEBO-CONTROLLED TRIAL | CORONARY-HEART-DISEASE | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Proprotein Convertases - antagonists & inhibitors | United States - epidemiology | Cardiovascular Diseases - prevention & control | Humans | Male | Incidence | Dose-Response Relationship, Drug | Antibodies, Monoclonal, Humanized | Cholesterol, VLDL - drug effects | Injections, Subcutaneous | Lipoproteins, LDL - drug effects | Cardiovascular Diseases - blood | Cardiovascular Diseases - epidemiology | Female | Serine Endopeptidases | Drug Therapy, Combination | Survival Rate - trends | Double-Blind Method | Drug Administration Schedule | Risk Assessment | Risk Factors | Treatment Outcome | Cholesterol, VLDL - blood | Australia - epidemiology | Antibodies, Monoclonal - administration & dosage | Norway - epidemiology | United Kingdom - epidemiology | Lipoproteins, LDL - blood | Proprotein Convertase 9 | Monoclonal antibodies | Blood circulation disorders | Low density lipoproteins | Risk factors | Vascular diseases | Clinical trials | Cardiovascular disease | Lipids | Cardiovascular diseases | Low density lipoprotein | Statins | Morbidity
Journal Article
Journal Article